Asia-Pacific Newborn Screening Market is expected to reach USD 432.41 million by 2025 growing at the highest CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Request for free sample: https://databridgemarketresearch.com/request-a-sample/?dbmr=apac-newborn-screening-market

The major factors contributing to the growth of the market includes factors such as growth in neonatal diseases and increased government initiatives.

Market Segmentation: Asia Pacific Newborn Screening Market

•The Asia-Pacific newborn screening market is segmented on the basis of test types into dried blood spot (DBS) test, critical congenital heart diseases (CCHD) test and hearing screen test. In 2018, dried blood spot segment is anticipated to lead the market with share of around 45%.

•The Asia-Pacific newborn screening market is segmented on the basis of technologies into tandem mass spectrometry, hearing screen, pulse oximetry screening, immunoassays and enzymatic assays, electrophoresis and DNA-based assays. In 2018, tandem mass spectrometry segment is likely to dominate the market with share of approximately 25.0%. It is expected to grow with the highest in the forecast period.

•The Asia-Pacific newborn screening market is segmented on the basis of product type into instruments and reagents & assay kits. In 2018, the instruments segment is estimated to dominate market with a share of around 70.0% and is projected to reach 298.02 million by 2025. The instruments are further sub-segmented into newborn disorder screening, newborn hearing screening, and pulse oximeter.

Inquire before buying: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=apac-newborn-screening-market

•The Asia-Pacific newborn screening market is divided on the basis of end user into hospitals, pediatric clinics, and clinics. In 2018, hospitals segment is expected to dominate market.

•The Asia-Pacific newborn screening market is segmented on the basis of disease type into phenylketonuria, cystic fibrosis, sickle cell disease, newborn hearing loss, critical congenital heart diseases, maple syrup urine disease and others. In 2018, critical congenital heart diseases segment will dominate the market.

Key Drivers: Asia Pacific Newborn Screening Market

Some of the major factors driving the market for Asia Pacific newborn screening market are growth in neonatal diseases and increased government initiatives.

Request for TOC: https://databridgemarketresearch.com/toc/?dbmr=apac-newborn-screening-market

Key Points: Asia Pacific Newborn Screening Market

PerkinElmer Inc. is going to dominate the Asia Pacific new born screening market followed by Natus Medical Incorporated and Trivitron Healthcare. PerkinElmer Inc., Trivitron Healthcare, Interacoustics A/S, Bio-Rad Laboratories, Inc., Natus Medical Incorporated, Masimo, Medtronic, Intelligent Hearing Systems, Interacoustics A/S, Otodynamics Ltd, Vivosonic Inc., ZenTech S.A., AB Sciex, Welch Allyn, Baebies, Inc.

• The dried blood spot segment is dominating the Asia Pacific new born screening market.

• The instruments segment is expected to dominate the new born screening market.

Know more @ https://databridgemarketresearch.com/reports/apac-newborn-screening-market/

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]